THE EFFICACY OF CORTICOSTEROID AFTER FACIAL NERVE NEURORRHAPHY: A SYSTEMATIC REVIEW

Desnita Monica

doi:10.53555/nnmhs.v9i8.1783

Authors

Desnita Monica Faculty of Medicine, Indonesian Islamic University, Indonesia Author

DOI:

https://doi.org/10.53555/nnmhs.v9i8.1783

Keywords:

Corticosteroid, Facial nerve neurorrhaphy, Complete facial nerve transection, Nerve regeneration, Functional recovery

Abstract

Background: In case of comple transection of facial nerve, it is unclear whether or not corticosteroids will be beneficial after facial nerve neurorrhaphy.

Aim: The purpose of this systematic review was to determine whether or not corticosteroids are effective in promoting facial nerve regeneration and functional recovery following complete transection and neurorrhaphy.

Methods: Randomized controlled trials on human and animal models from Ovid MEDLINE and Ovid EMBASE that studied the efficacy of corticosteroids in total facial nerve damage followed by neurorrhaphy. Electrophysiology, histology, and functional recovery were the methods that were used to evaluate the results. On the other hand, there was no randomised controlled experiment carried out on humans. In a clinical context, it's possible that it won't be possible to conduct human trials that involve histology.

Results: Six animal investigations with a total of 248 participants met the inclusion criteria. Electrophysiological results revealed no differences between systemic corticosteroids and controls in terms of latency and amplitude. The results of a comparison between topical corticosteroid and the control group revealed no differences in latency and amplitude. In histologic outcomes, there were no differences in axon diameter between the systemic corticosteroid and control groups; however, the control group had thicker myelin. Comparing systemic corticosteroid to a placebo in terms of eye blinking, the results favoured the placebo.

Conclusion: When analysing electrophysiologic and functional recovery outcomes in animal models, this study did not demonstrate any possible benefits of systemic or topical corticosteroid administrations after facial nerve neurorrhaphy in complete transection.

References

Condie D, Tolkachjov SN. Facial Nerve Injury and Repair: A Practical Review for Cutaneous Surgery. Vol. 45, Dermatologic Surgery. 2019.

Lee PH, Liang CC, Huang SF, Liao HT. The outcome analysis of traumatic facial nerve palsy treated with systemic steroid therapy. J Craniofac Surg. 2018;29(7).

Pernambuco L, Espelt A, Góis ACB, de Lima KC. Voice Disorders in Older Adults Living in Nursing Homes: Prevalence and Associated Factors. J Voice [Internet] 2017;31(4):510.e15-510.e21. Available from: http://dx.doi.org/10.1016/j.jvoice.2016.11.015

Aminoff MJ, Daroff RB. Encyclopedia of the Neurological Sciences. Encyclopedia of the Neurological Sciences. 2014.

Cayli SR, Kocak A, Yilmaz U, Tekiner A, Erbil M, Ozturk C, et al. Effect of combined treatment with melatonin and methylprednisolone on neurological recovery after experimental spinal cord injury. Eur Spine J. 2004;13(8).

Genovese T, Mazzon E, Crisafulli C, Di Paola R, Muià C, Bramanti P, et al. Immunomodulatory effects of etanercept in an experimental model of spinal cord injury. J Pharmacol Exp Ther. 2006;316(3).

Tsutsumi S, Ueta T, Shiba K, Yamamoto S, Takagishi K. Effects of the second national acute spinal cord injury study of high-dose methylprednisolone therapy on acute cervical spinal cord injury - Results in spinal injuries center. Spine (Phila Pa 1976). 2006;31(26).

Madhok VB, Gagyor I, Daly F, Somasundara D, Sullivan M, Gammie F, et al. Corticosteroids for Bell’s palsy (idiopathic facial paralysis). Vol. 2016, Cochrane Database of Systematic Reviews. 2016.

Baugh RF, Basura GJ, Ishii LE, Schwartz SR, Drumheller CM, Burkholder R, et al. Clinical Practice Guideline: Bell’s Palsy. Otolaryngol Neck Surg. 2013;149.

X. F, L. T, C. W, M. L, H. W, J. L, et al. A network meta-analysis to compare the efficacy of steroid and antiviral medications for facial paralysis from bell’s palsy. Pain Physician. 2018;21(6).

Sun DQ, Andresen NS, Gantz BJ. Surgical Management of Acute Facial Palsy. Vol. 51, Otolaryngologic Clinics of North America. 2018.

Kannan RY, Hills A, Shelley MJ, Bisase B, Kapoor K, Norris P, et al. Immediate compared with late repair of extracranial branches of the facial nerve: a comparative study. Br J Oral Maxillofac Surg. 2020;58(2).

Higgins JPT, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343(7829).

Seth R, Revenaugh PC, Kaltenbach JA, Rajasekaran K, Meltzer NE, Ghosh D, et al. Facial nerve neurorrhaphy and the effects of glucocorticoids in a rat model. Otolaryngol - Head Neck Surg (United States). 2012;147(5).

Edizer DT, Dönmez Z, Gül M, Yiğit Ö, Yiğitcan B, Adatepe T, et al. Effects of melatonin and dexamethasone on facial nerve neurorrhaphy. J Int Adv Otol. 2019;15(1).

Longur ES, Yiğit Ö, Kalaycık Ertugay Ç, Araz Server E, Adatepe T, Akakın D, et al. Effect of Bumetanide on Facial Nerve Regeneration in Rat Model. Otolaryngol - Head Neck Surg (United States). 2021;164(1).

Yanilmaz M, Akduman D, Sagun ÖF, Haksever M, Yazicilar O, Orhan I, et al. The effects of aminoguanidine, methylprednisolone, and melatonin on nerve recovery in peripheral facial nerve neurorrhaphy. J Craniofac Surg. 2015;26(3).

Karlidag T, Yildiz M, Yalcin S, Colakoglu N, Kaygusuz I, Sapmaz E. Evaluation of the effect of methylprednisolone and N-acetylcystein on anastomotic degeneration and regeneraton of the facial nerve. Auris Nasus Larynx. 2012;39(2).

Yildirim MA ki., Karlidag T, Akpolat N, Kaygusuz I, Keles E, Yalcin S, et al. The effect of methylprednisolone on facial nerve paralysis with different etiologies. J Craniofac Surg. 2015;26(3).